Skip to content

Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants

Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03187730
Enrollment
410
Registered
2017-06-15
Start date
2017-09-22
Completion date
2021-04-30
Last updated
2021-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Smoking Cassation, Immigrants, Economic Disparity

Brief summary

This is a 24 month pilot project that will implement and evaluate an innovative program that integrates financial counseling with smoking cessation counseling for low-income immigrants.

Detailed description

This is a two-arm randomized, wait-list control study with 610 participants total: 600 patient participants and 10 staff participants. 600 smokers will be recruited to complete a 9-week intervention that integrates financial management and smoking cessation counseling. Participants will be randomized (300 per arm, stratified by site) to receive the intervention immediately after enrolling (Intervention Arm) or 6 months later (Waitlist Control Arm). Both arms will receive nicotine replacement therapy (NRT) for four weeks as part of their time in integrative counseling. Participants will be observed at baseline, 2 months, 6 months and 12 months to assess outcomes and their satisfaction with treatment.

Interventions

BEHAVIORALIntegrated Smoking Cessation and Financial Counseling

Participants in the intervention group will receive up to nine counseling sessions that integrate two evidence-based counseling approaches: financial management counseling and smoking cessation counseling. Participants will also be eligible to receive a free four-week supply of NRT. Participants will be surveyed at baseline, 2- months, 6-months and 12-months to assess outcomes and treatment satisfaction.

BEHAVIORALWaitlist Integrated Smoking Cessation and Financial Counseling

Control participants in the waitlist control group will receive usual care for the first 6 months of the study, while the Intervention Arm receives integrated counseling. The waitlist control group will receive the same counseling program as the Intervention group 6 months after enrollment (up to nine counseling sessions and four weeks of NRT). Participants will be surveyed at baseline, 2-months, 6-months and 12-months to assess outcomes and treatment satisfaction.

DRUGNicotine Replacement Therapy (NRT)

Participants in both arms will be eligible to receive a free four-week supply of NRT.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Smokes ≥5 cigarettes per day * Born outside the U.S. * Interested in receiving smoking and financial counseling * Self-reported income below 200% of the current federal poverty level for a given household composition * New York City resident * English or Spanish language * Able to provide informed consent, and * Does not have a representative who manages his/her funds (to ensure the participant has the ability to manage household money). We will exclude participants who report being pregnant or breastfeeding (unable to receive NRT). Hospital staff participants: * Must be current medical or non-medical provider or administrator at Bellevue Hospital or New York University Lutheran Medical Center

Exclusion criteria

* We will exclude participants who report being pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frameDescription
% of Participants Who Had Smoked Cigarette(s) in the Past 7 Days (at 6 Months From Baseline)6 MonthsParticipants answered In the past 7 days, have you smoked a cigarette? (yes/no); % of yes is reported per arm

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention Arm
Integrated Smoking Cessation and Financial Counseling: Participants in the intervention group will receive up to nine counseling sessions that integrate two evidence-based counseling approaches: financial management counseling and smoking cessation counseling. Participants will also be eligible to receive a free four-week supply of NRT. Participants will be surveyed at baseline, 2- months, 6-months and 12-months to assess outcomes and treatment satisfaction. Nicotine Replacement Therapy (NRT): Participants in both arms will be eligible to receive a free four-week supply of NRT.
208
Waitlist Control
Waitlist Integrated Smoking Cessation and Financial Counseling: Control participants in the waitlist control group will receive usual care for the first 6 months of the study, while the Intervention Arm receives integrated counseling. The waitlist control group will receive the same counseling program as the Intervention group 6 months after enrollment (up to nine counseling sessions and four weeks of NRT). Participants will be surveyed at baseline, 2-months, 6-months and 12-months to assess outcomes and treatment satisfaction. Nicotine Replacement Therapy (NRT): Participants in both arms will be eligible to receive a free four-week supply of NRT.
202
Total410

Baseline characteristics

CharacteristicIntervention ArmTotalWaitlist Control
Age, Continuous53.2 years52.85 years52.5 years
Ethnicity (NIH/OMB)
Hispanic or Latino
105 Participants222 Participants117 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
103 Participants188 Participants85 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
6 Participants15 Participants9 Participants
Race (NIH/OMB)
Asian
3 Participants5 Participants2 Participants
Race (NIH/OMB)
Black or African American
98 Participants190 Participants92 Participants
Race (NIH/OMB)
More than one race
7 Participants23 Participants16 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
51 Participants94 Participants43 Participants
Race (NIH/OMB)
White
42 Participants81 Participants39 Participants
Region of Enrollment
United States
208 participants410 participants202 participants
Sex: Female, Male
Female
69 Participants146 Participants77 Participants
Sex: Female, Male
Male
139 Participants264 Participants125 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
3 / 2081 / 202
other
Total, other adverse events
0 / 2080 / 202
serious
Total, serious adverse events
11 / 2085 / 202

Outcome results

Primary

% of Participants Who Had Smoked Cigarette(s) in the Past 7 Days (at 6 Months From Baseline)

Participants answered In the past 7 days, have you smoked a cigarette? (yes/no); % of yes is reported per arm

Time frame: 6 Months

ArmMeasureValue (NUMBER)
Intervention Arm% of Participants Who Had Smoked Cigarette(s) in the Past 7 Days (at 6 Months From Baseline)27 % of participants
Waitlist Control% of Participants Who Had Smoked Cigarette(s) in the Past 7 Days (at 6 Months From Baseline)13 % of participants

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026